BioVaxys Technology Corp Sustainability Reports
BioVaxys Technology Corp. is a clinical-stage biotechnology company that develops viral and oncology vaccine platforms and immuno-diagnostics. Its focus includes bi-haptenized cancer vaccines and the DPX immunotherapeutic platform technology.
Sector: Manufacturing
Country: Canada
Exchange: Canadian Securities Exchange
LEI: 894500UD22QWRLZYJ229
2 reports from 2023 to 2024
